The event, part of the #CheckYourFoodTube campaign, was held in Cincinnati, Ohio.
Lucid Diagnostics launched its first-ever #CheckYourFoodTube Precancer Testing Event in Cincinnati, Ohio.1 The campaign is focused on educating the connection between gastroesphageal reflux disease and esophageal cancer. The disease is more commonly known as chronic heartburn,
The campaign is targeted at former NFL players. The first event featured an educational section, which was followed by on-site testing for the former players.
In a press release, former Cincinnati Bengals player and team leader of the Sports-Health Alliance at Russo Partners Solomon Wilcots said, “Collaborating with Lucid Diagnostics on this inaugural event is just the beginning of what we hope will be a game-changing initiative for former NFL players across the country. As athletes who've put our bodies on the line throughout our careers, we have a heightened awareness of the importance of protecting our long-term health. EsoGuard offers us a crucial opportunity for early detection of esophageal precancer, which can truly be a lifesaver. I strongly encourage all my peers in the sports community to take proactive steps in safeguarding their health from this deadly, yet preventable cancer. Remember, when it comes to esophageal cancer, early detection is the best—it's time we all 'Check Our Food Tubes!'"
Lucid chairman and CEO Lishan Aklog added, “These educational and precancer testing events targeting former NFL players provide us with a great opportunity to increase awareness of highly lethal but now preventable esophageal cancer. Individuals with heartburn and other risk factors (age over 50, male, white race, obesity, smoking, or a family history), whether former NFL players or their legions of fans, can now undergo a quick and simple test to determine whether they may have precancer and take appropriate steps to prevent this cancer. We are committed to getting the word out and appreciate Mr. Wilcots and his compatriots using their platform to help us do so."
Lucid also recently signed a memorandum of understanding with Front Line Mobile Health.2 This partnership will result in co-marketing initiatives targeted at firefighters.
In a press release issued in early September, Lucid president and chief operating officer Shaun O’Neil said, “Lucid Diagnostics is committed to widespread early detection of esophageal precancer. We are honored to have provided EsoGuard precancer testing to thousands of firefighters across the nation. Every day they risk their lives to protect us, and Lucid is committed to protecting them in return. This partnership allows us to expand these efforts by leveraging Front Line's resources and extensive expertise caring for firefighters. We are excited to further collaborate with Front Line to increase access to esophageal precancer testing for firefighters and drive revenue through contracted high-volume testing events."
In the same press release, Front Line team principal and CEO Russell A. Burnham added, “At Front Line Mobile Health, we are deeply committed to protecting the health and safety of our nation's firefighters, who face a 62% higher risk of developing esophageal cancer. Lucid's EsoGuard Esophageal DNA Test is a powerful tool in this endeavor, offering early detection of esophageal precancer and thereby safeguarding the well-being of these brave individuals. We look forward to expanding our partnership with Lucid and leveraging our strong relationships with fire departments to broaden access to this potentially life-saving tool."
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.